Obesity and hypertension (Review)

Jiang,Shu‑Zhong; Lu,Wen; Zong,Xue‑Feng; Ruan,Hong‑Yun; Liu,Yi

doi:10.3892/etm.2016.3667

Obesity and hypertension (Review)

Authors:
- Shu‑Zhong Jiang
- Wen Lu
- Xue‑Feng Zong
- Hong‑Yun Ruan
- Yi Liu
View Affiliations

Affiliations: Department of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China
Published online on: September 6, 2016 https://doi.org/10.3892/etm.2016.3667
Pages: 2395-2399
Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The imbalance between energy intake and expenditure is the main cause of excessive overweight and obesity. Technically, obesity is defined as the abnormal accumulation of ≥20% of body fat, over the individual's ideal body weight. The latter constitutes the maximal healthful value for an individual that is calculated based chiefly on the height, age, build and degree of muscular development. However, obesity is diagnosed by measuring the weight in relation to the height of an individual, thereby determining or calculating the body mass index. The National Institutes of Health have defined 30 kg/m2 as the limit over which an individual is qualified as obese. Accordingly, the prevalence of obesity in on the increase in children and adults worldwide, despite World Health Organization warnings. The growth of obesity and the scale of associated health issues induce serious consequences for individuals and governmental health systems. Excessive overweight remains among the most neglected public health issues worldwide, while obesity is associated with increasing risks of disability, illness and death. Cardiovascular diseases, the leading cause of mortality worldwide, particularly hypertension and diabetes, are the main illnesses associated with obesity. Nevertheless, the mechanisms underlying obesity‑associated hypertension or other associated metabolic diseases remains to be adequately investigated. In the present review, we addressed the association between obesity and cardiovascular disease, particularly the biological mechanisms linking obesity and hypertension.

View Figures

View References

1	Crawford DA, Jeffery RW and French SA: Television viewing, physical inactivity and obesity. Int J Obes Relat Metab Disord. 23:437–440. 1999. View Article : Google Scholar : PubMed/NCBI
2	Kitahara CM, Flint AJ, de Gonzalez A Berrington, Bernstein L, Brotzman M, MacInnis RJ, Moore SC, Robien K, Rosenberg PS, Singh PN, et al: Association between class III obesity (BMI of 40-59 kg/m²) and mortality: A pooled analysis of 20 prospective studies. PLoS Med. 11:e10016732014. View Article : Google Scholar : PubMed/NCBI
3	Gill T, King L and Caterson I: Obesity prevention: Necessary and possible A structured approach for effective planning. Proc Nutr Soc. 64:255–261. 2005. View Article : Google Scholar : PubMed/NCBI
4	O'Connor DW: The impact of obesity on national and homeland security. Naval Postgraduate School; Monterey, CA: 2013
5	Murray CJ and Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 349:1269–1276. 1997. View Article : Google Scholar : PubMed/NCBI
6	Bloomgarden ZT: Third Annual World Congress on the Insulin Resistance Syndrome: Associated conditions. Diabetes Care. 29:2165–2174. 2006. View Article : Google Scholar : PubMed/NCBI
7	Strumpf E: The obesity epidemic in the United States: causes and extent, risks and solutions. The Commonwealth Fund; New York, NY: 2004
8	Hall JE, Crook ED, Jones DW, Wofford MR and Dubbert PM: Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 324:127–137. 2002. View Article : Google Scholar : PubMed/NCBI
9	Frohlich ED: Clinical management of the obese hypertensive patient. Cardiol Rev. 10:127–138. 2002. View Article : Google Scholar : PubMed/NCBI
10	Hall JE, Brands MW, Hildebrandt DA, Kuo J and Fitzgerald S: Role of sympathetic nervous system and neuropeptides in obesity hypertension. Braz J Med Biol Res. 33:605–618. 2000. View Article : Google Scholar : PubMed/NCBI
11	Hall JE: Pathophysiology of obesity hypertension. Curr Hypertens Rep. 2:139–147. 2000. View Article : Google Scholar : PubMed/NCBI
12	Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S and Zakopoulos N: Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension. 45:602–607. 2005. View Article : Google Scholar : PubMed/NCBI
13	Stabouli S, Kotsis V, Papamichael C, Constantopoulos A and Zakopoulos N: Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr. 147:651–656. 2005. View Article : Google Scholar : PubMed/NCBI
14	Portela DS, Vieira TO, Matos SM, de Oliveira NF and Vieira GO: Maternal obesity, environmental factors, cesarean delivery and breastfeeding as determinants of overweight and obesity in children: Results from a cohort. BMC Pregnancy Childbirth. 15:942015. View Article : Google Scholar : PubMed/NCBI
15	Rosenbaum M and Leibel RL: The physiology of body weight regulation: Relevance to the etiology of obesity in children. Pediatrics. 101:525–539. 1998.PubMed/NCBI
16	Racette SB, Deusinger SS, Strube MJ, Highstein GR and Deusinger RH: Weight changes, exercise, and dietary patterns during freshman and sophomore years of college. J Am Coll Health. 53:245–251. 2005. View Article : Google Scholar : PubMed/NCBI
17	Nestle M and Jacobson MF: Halting the obesity epidemic: A public health policy approach. Public Health Rep. 115:12–24. 2000. View Article : Google Scholar : PubMed/NCBI
18	Mirowsky J and Ross CE: Social causes of psychological distress. Transaction Publishers; New Jersey, NJ: 2003
19	Spiegelman BM and Flier JS: Obesity and the regulation of energy balance. Cell. 104:531–543. 2001. View Article : Google Scholar : PubMed/NCBI
20	Guyenet SJ and Schwartz MW: Clinical review: Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J Clin Endocrinol Metab. 97:745–755. 2012. View Article : Google Scholar : PubMed/NCBI
21	Life JS: The Life Plan Diet: How Losing Belly Fat is the Key to Gaining a Stronger, Sexier, Healthier Body. Simon and Schuster; New York, NY: 2014
22	Gaman PM and Sherrington KB: The science of food: an introduction to food science, nutrition and microbiology. Elsevier; 2013
23	Kwok CY, Wong CNY, Yau MYC, Yu PHF, Au ALS, Poon CCW, Seto SW, Lam TY, Kwan YW and Chan SW: Consumption of dried fruit of Crataegus pinnatifida (hawthorn) suppresses high-cholesterol diet-induced hypercholesterolemia in rats. J Funct Foods. 2:179–186. 2010. View Article : Google Scholar
24	Ledwozyw A, Michalak J, Stepień A and Kadziołka A: The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta. 155:275–283. 1986. View Article : Google Scholar : PubMed/NCBI
25	Matsuzawa Y: Metabolic syndrome - definition and diagnostic criteria in Japan. J Atheroscler Thromb. 12:301. 2005. View Article : Google Scholar : PubMed/NCBI
26	Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
27	Kotsis VT, Stabouli SV, Papamichael CM and Zakopoulos NA: Impact of obesity in intima media thickness of carotid arteries. Obesity (Silver Spring). 14:1708–1715. 2006. View Article : Google Scholar : PubMed/NCBI
28	Wong LK: Global burden of intracranial atherosclerosis. Int J Stroke. 1:158–159. 2006. View Article : Google Scholar : PubMed/NCBI
29	Taylor WC and Landau WM: Atherosclerosis and stroke. Ann Neurol. 28:108–109. 1990. View Article : Google Scholar : PubMed/NCBI
30	Pico F, Labreuche J, Touboul PJ and Amarenco P: GENIC Investigators: Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype. Neurology. 61:1736–1742. 2003. View Article : Google Scholar : PubMed/NCBI
31	Joki N, Hase H, Takahashi Y, Ishikawa H, Nakamura R, Imamura Y, Tanaka Y, Saijyo T, Fukazawa M, Inishi Y, et al: Angiographical severity of coronary atherosclerosis predicts death in the first year of hemodialysis. Int Urol Nephrol. 35:289–297. 2003. View Article : Google Scholar : PubMed/NCBI
32	Landsberg L and Krieger DR: Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens. 2:125S–132S. 1989.PubMed/NCBI
33	Rocchini AP, Yang JQ and Gokee A: Hypertension and insulin resistance are not directly related in obese dogs. Hypertension. 43:1011–1016. 2004. View Article : Google Scholar : PubMed/NCBI
34	Coatmellec-Taglioni G and Ribière C: Factors that influence the risk of hypertension in obese individuals. Curr Opin Nephrol Hypertens. 12:305–308. 2003. View Article : Google Scholar : PubMed/NCBI
35	Wofford MR, Adair C, Anderson DC, Hall JE, Miller MM and Jones DW: Alpha and beta adrenergic blockade in obese and lean hypertensive subjects. Hypertension,. 32:5951998.
36	Hall JE: Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 23:381–394. 1994.
37	Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX and Eckel RH; American Heart Association: Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 113:898–918. 2006. View Article : Google Scholar : PubMed/NCBI
38	Manes JL, Taylor HB and Starkloff GB: Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients. J Clin Pathol. 26:776–783. 1973. View Article : Google Scholar : PubMed/NCBI
39	Deipolyi AR, Fang S, Palop JJ, Yu GQ, Wang X and Mucke L: Altered navigational strategy use and visuospatial deficits in hAPP transgenic mice. Neurobiol Aging. 29:253–266. 2008. View Article : Google Scholar : PubMed/NCBI
40	Costa D, Barbalho MC, Miguel GP, Forti EM and Azevedo JL: The impact of obesity on pulmonary function in adult women. Clinics (Sao Paulo). 63:719–724. 2008. View Article : Google Scholar : PubMed/NCBI
41	DeClercq V, McMurray DN and Chapkin RS: Obesity promotes colonic stem cell expansion during cancer initiation. Cancer Lett. 369:336–343. 2015. View Article : Google Scholar : PubMed/NCBI
42	Gallagher S: The challenges of obesity and skin integrity. Nurs Clin North Am. 40:325–335. 2005. View Article : Google Scholar : PubMed/NCBI
43	van Gaal LF, Mertens IL and De Block CE: Mechanisms linking obesity with cardiovascular disease. Nature. 444:875–880. 2006. View Article : Google Scholar : PubMed/NCBI
44	Cazettes F, Cohen JI, Yau PL, Talbot H and Convit A: Obesity-mediated inflammation may damage the brain circuit that regulates food intake. Brain Res. 1373:101–109. 2011. View Article : Google Scholar : PubMed/NCBI
45	Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M, et al: Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol. 296:F118–F126. 2009. View Article : Google Scholar : PubMed/NCBI
46	Kincaid-Smith P: Hypothesis: Obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled ‘hypertensive nephrosclerosis’. J Hypertens. 22:1051–1055. 2004. View Article : Google Scholar : PubMed/NCBI
47	Serra A, Romero R, Lopez D, Navarro M, Esteve A, Perez N, Alastrue A and Ariza A: Renal injury in the extremely obese patients with normal renal function. Kidney Int. 73:947–955. 2008. View Article : Google Scholar : PubMed/NCBI
48	Praga M and Morales E: Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens. 15:481–486. 2006. View Article : Google Scholar : PubMed/NCBI
49	Cignarelli M and Lamacchia O: Obesity and kidney disease. Nutr Metab Cardiovasc Dis. 17:757–762. 2007. View Article : Google Scholar : PubMed/NCBI
50	Bagby SP: Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol. 15:2775–2791. 2004. View Article : Google Scholar : PubMed/NCBI
51	Kambham N, Markowitz GS, Valeri AM, Lin J and D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int. 59:1498–1509. 2001. View Article : Google Scholar : PubMed/NCBI
52	Ordway RW, Singer JJ and Walsh JV Jr: Direct regulation of ion channels by fatty acids. Trends Neurosci. 14:96–100. 1991. View Article : Google Scholar : PubMed/NCBI
53	Khan WA, Blobe G, Halpern A, Taylor W, Wetsel WC, Burns D, Loomis C and Hannun YA: Selective regulation of protein kinase C isoenzymes by oleic acid in human platelets. J Biol Chem. 268:5063–5068. 1993.PubMed/NCBI
54	Oishi K, Zheng B and Kuo JF: Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid. J Biol Chem. 265:70–75. 1990.PubMed/NCBI
55	Ferrario CM and Schiavone MT: The renin-angiotensin system: Importance in physiology and pathology. Cleve Clin J Med. 56:439–446. 1989. View Article : Google Scholar : PubMed/NCBI
56	Yiannikouris F, Karounos M, Charnigo R, English VL, Rateri DL, Daugherty A and Cassis LA: Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol. 302:R244–R251. 2012. View Article : Google Scholar : PubMed/NCBI
57	Guyton AC: The surprising kidney-fluid mechanism for pressure control - its infinite gain. Hypertension. 16:725–730. 1990. View Article : Google Scholar : PubMed/NCBI
58	Hall JE: Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens. 10:49S–55S. 1997. View Article : Google Scholar : PubMed/NCBI
59	Tuck ML, Sowers J, Dornfeld L, Kledzik G and Maxwell M: The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med. 304:930–933. 1981. View Article : Google Scholar : PubMed/NCBI
60	Taddei S, Virdis A, Mattei P, Favilla S and Salvetti A: Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. Hypertension. 25:595–601. 1995. View Article : Google Scholar : PubMed/NCBI
61	Maser RE and Lenhard MJ: An overview of the effect of weight loss on cardiovascular autonomic function. Curr Diabetes Rev. 3:204–211. 2007. View Article : Google Scholar : PubMed/NCBI
62	Stepniakowski KT, Goodfriend TL and Egan BM: Fatty acids enhance vascular α-adrenergic sensitivity. Hypertension. 25:774–778. 1995. View Article : Google Scholar : PubMed/NCBI
63	Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, et al: American Heart Association Nutrition Committee: Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation. 114:82–96. 2006. View Article : Google Scholar : PubMed/NCBI
64	Mavanji V, Billington CJ, Kotz CM and Teske JA: Sleep and obesity: A focus on animal models. Neurosci Biobehav Rev. 36:1015–1029. 2012. View Article : Google Scholar : PubMed/NCBI
65	Koopman RJ, Swofford SJ, Beard MN and Meadows SE: Obesity and metabolic disease. Prim Care. 36:257–270. 2009. View Article : Google Scholar : PubMed/NCBI